|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptives containing desogestrel in the maintenance of the |
| remission of hirsutism: monthly versus bimonthly treatment. |
| CONTRACEPTION. 1991 Nov;44(5):533-40. |
| A treatment to keep hirsutism in remission while minimizing lipid disturbances was attempted in 20 formerly hirsute |
| patients with hirsutism scores already greatly reduced after oral contraceptive (OC) treatment. After OC |
| discontinuation for 1-3 months, they were thereafter treated for 2 years in the following way: 9 patients received |
| ethinyl estradiol (30 mcg/day) + desogestrel (150 mcg/day) in 3-week cycles every month; 6 patients received the |
| same formulation during 3-week cycles ever other month (bimonthly); and 5 patients received no treatment. In the |
| untreated group, abnormal hirsutism scores reappeared within 12-18 months; the levels of testosterone and free |
| testosterone, initially high following discontinuation of OCs, remained elevated. Monthly treatment kept hirsutism in |
| remission, and testosterone and free testosterone levels decreased. Bimonthly treatment was equally effective in |
| keeping hirsutism in remission, although testosterone levels did not decrease. Bimonthly treatment was not better |
| than monthly treatment in relation to plasma lipid changes (cholesterol, HDL cholesterol, and triglycerides). |
| (author's) (PubHealth.info Document ID: CONT3T 2005-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives containing desogestrel in the |
| maintenance of the remission of hirsutism: monthly versus bimonthly treatment.", is(are) Porcile A; Gallardo E. The |
| source of this article is "CONTRACEPTION. 1991 Nov;44(5):533-40.". This article was published in 1991 in English |
| language(s). (PubHealth.info® Document ID: CONT3T 2005-06. All rights reserved with PubHealth.info) PIN: 12005 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |